Abstract
Background: Mutations in the gene encoding AT- Rich Interactive Domain-containing protein 1A (ARID1A) occur in several cancer types with varying frequency. The predictive impact of ARID1A mutations on platinum-based chemotherapy and immunotherapy have been investigated retrospectively, yielding conflicting results. We report our analysis on the predictive impact of ARID1A status – mutated (MUT) versus (vs.) wild type (WT) – in metastatic solid tumor patients who were exposed to platinum-based chemotherapy and immunotherapy.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
